Skip to content
Peptigraph home

Does retatrutide help with insulin resistance?

No source reports a direct insulin-resistance test such as a clamp; a phase 2 metabolite analysis found retatrutide associated with changes in metabolites linked to insulin resistance.

GLP-1 / GIP / glucagon triple agonistUpdated

Short answer

No source reports a direct insulin-resistance test such as a clamp; a phase 2 metabolite analysis found retatrutide associated with changes in metabolites linked to insulin resistance.[1]

What the sources show

The same analysis said these changes appeared in both study populations and were sustained across study endpoints.[1]

In the liver-fat substudy, fat reductions were significantly related to changes in measures tied to improved insulin sensitivity and lipid metabolism; this is an association, not proof of cause.[2]

Retatrutide pairs glucagon activity, which raises blood sugar, with GLP-1 activity, which stimulates insulin secretion to lower it, according to a review of glucagon-based drugs.[3]

More on Retatrutide

Sources

  1. 1Retatrutide And Lipid And Metabolite Profiles In Participants With Obesity With Or Without Type 2 Diabetes.The Journal of clinical endocrinology and metabolism · 2026PMID 42135195Accessed 2 Oct 2026
  2. 2Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.Nature medicine · 2024PMID 38858523Accessed 2 Oct 2026
  3. 3Shared mechanistic pathways of glucagon signalling: Unlocking its potential for treating obesity, metabolic dysfunction-associated steatotic liver disease, and other cardio-kidney-metabolic conditions.Diabetes, obesity & metabolism · 2025PMID 41025406Accessed 2 Oct 2026

Found an error? Report a correction.